Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
about
Prophylaxis of contrast-induced nephrotoxicityAnalysis of aspirin-associated risks in healthy individualsAnaphylactoid and anaphylactic reactions to iodinated contrast material.Reactions to radiocontrast material. Anaphylactoid events in radiology.Risk factors for adverse reactions from contrast agents for computed tomography.Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy.Review article: Effects of radiographic contrast media on the lung.Contrast-induced nephropathy in interventional cardiologyDoes radio-opaque contrast improve radiographic localisation of percutaneous central venous lines?Correlation of abdominal fat ratio with hepatic CT enhancementAllergy-like reactions to iodinated contrast agents. A critical analysis.Anaphylactic Shock Following Nonionic Contrast Medium during Caudal Epidural InjectionReview article: Acute serious and fatal reactions to contrast media: our current understanding.Contrast material-induced renal failure: an overview.Safety of iobitridol in the general population and at-risk patients.Current understanding of contrast media reactions and implications for clinical management.Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients.Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy.Contrast media and clotting: what is the evidence?The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure.Incidence and risk factors of contrast-induced nephropathy after bronchial arteriography or bronchial artery embolization.Multi-detector row CT of the head and neck: comparison of different volumes of contrast material with and without a saline chaser.Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE).Contrast-induced nephropathy in urological imaging: A comparison with cardiology interventions.Nephroprotective Effects of L-Carnitine against Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Open-Labeled Clinical Trial.Suspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillance.Uncertainty and Its Consequences in Clinical Practice.Prevalence of adverse reactions to radiopaque contrast reported by patients presenting for interventional pain procedure.Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India.Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.Irreversible deterioration of estimated glomerular filtration rate in patients with acute myocardial infarction after primary percutaneous coronary intervention.Informed consent in diagnostic radiology practice: Where do we stand?Carotid artery stenting: single-center experience over 11 years.CT angiography is cost-effective for confirmation of internal carotid artery occlusions.
P2860
Q27012899-DA90CEE6-33D4-4A9F-80EE-9A96DA0163ABQ28211608-C127EEC6-D1A9-4D81-B7CB-021D2C7816E5Q33874312-8BF28243-6A02-489D-85BE-126017D4D637Q33928987-BBF7B644-11AC-4D27-AD74-50582DDFC4D5Q34567641-6624E88A-A675-4A5D-B709-A64E9431F18BQ35083828-B3CED2AE-0772-4803-A0F6-45E6C1719631Q35134817-40A45A72-DE60-4A37-BDCA-F2C0DAAB2BA3Q35193141-BC747F75-A6D6-4CE9-A903-85868AA23B15Q35294205-3EC8F5F9-6497-47DB-B0B8-8549B98150D1Q35803137-5B13A8AB-F473-4566-B2F3-E06C9950A23DQ36135580-A1636772-93D6-468D-943A-EA7CDF6B03D6Q36177238-95F4902A-52DD-4779-A823-7A0C7C315B20Q36208379-4630E57F-68A7-4D87-9DA2-F42D40C581C2Q36335159-53AB219D-B969-4B09-AA34-86866B538E82Q36374998-532BE039-21CE-43CB-8566-F82F6CBA2A2EQ36384726-30831415-DB5B-44BD-AF61-37D4EDE72B80Q37231282-F78C329B-13A8-4BEF-99B4-806A9910D2D9Q37477897-FEC75E51-8B22-4BDC-85CF-50F2F92AE8E3Q37718115-5CD29977-BE96-4DFB-A3C2-21AF564AD27CQ37903799-7071BB75-769D-4F7A-A4F3-A1990C4B2F5FQ38450387-F9989894-F41E-4907-A072-D61137C79F02Q38508757-7B5AF3C6-D555-4FC7-AFF7-1FB6600D9B52Q40012815-E10B0DD4-90F3-4BE6-AEF0-30D9DF8B4D7CQ41002393-93F98EB5-4176-4894-AF7D-88E7CF78A2A2Q41425082-35A59B26-98E4-4CA8-B6FE-F3FF2AAFBA90Q41601832-FBB0F6DF-73FE-4098-86B5-44AC5322694BQ41867436-4F58D36A-19C9-4866-90F9-3A661FE6D492Q43472947-45DC3CE2-C2A9-486D-A904-04AB8660099DQ44171942-9E90635E-1B0B-4FCB-9169-7AE1C3D05BDCQ48133933-80ED747D-AA0E-476E-8935-9B480A3D8EECQ48152409-622C4C81-D12F-43CC-9C89-4D1DA015AB4EQ48510709-808CFC4A-DC28-48CA-AD0C-F3904EB11284Q50182200-C0E6003F-F263-4CB0-9C32-484FDDAE5037Q53431011-9E3CA8AA-C78C-43C5-9EF2-51DB7824DE6E
P2860
Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Reports on contrast media reac ...... Food and Drug Administration.
@ast
Reports on contrast media reac ...... Food and Drug Administration.
@en
Reports on contrast media reac ...... Food and Drug Administration.
@nl
type
label
Reports on contrast media reac ...... Food and Drug Administration.
@ast
Reports on contrast media reac ...... Food and Drug Administration.
@en
Reports on contrast media reac ...... Food and Drug Administration.
@nl
prefLabel
Reports on contrast media reac ...... Food and Drug Administration.
@ast
Reports on contrast media reac ...... Food and Drug Administration.
@en
Reports on contrast media reac ...... Food and Drug Administration.
@nl
P2093
P1433
P1476
Reports on contrast media reac ...... Food and Drug Administration.
@en
P2093
P304
P356
10.1148/RADIOLOGY.203.3.9169676
P407
P577
1997-06-01T00:00:00Z